Cargando…
Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
Breast cancer represents the number one cause of cancer-associated mortality globally. The most aggressive molecular subtype is triple negative breast cancer (TNBC), of which limited therapeutic options are available. It is well known that breast cancer prognosis and tumor sensitivity toward immunot...
Autores principales: | Lv, Yufei, Lv, Dongxu, Lv, Xiaohong, Xing, Ping, Zhang, Jianguo, Zhang, Yafang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017297/ https://www.ncbi.nlm.nih.gov/pubmed/33815462 http://dx.doi.org/10.3389/fgene.2021.616469 |
Ejemplares similares
-
LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer
por: Lv, Yufei, et al.
Publicado: (2021) -
Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022) -
Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022) -
The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognosis
por: Zhang, Yongsheng, et al.
Publicado: (2022) -
Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing
por: Gong, Shasha, et al.
Publicado: (2020)